Clinical trial · Observational
Evaluation of Neoplasia With Artificial Intelligence in Gastrointestinal Endoscopy
Collection of Endoscopic Images and Videos for Validation of Artificial Intelligence Algorithms for Computer Aided Detection and Characterisation of Early Gastrointestinal Neoplasia
NCT04937647CI-TRIAL-00099527NEW-AGEcompletedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 18, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260918-000001
Summary
Brief summary (as posted)
This study aims to validate and evaluate AI algorithms for detection and characterization of early GI neoplasia.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Gastrointestinal Neoplasms | Digestive System Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| collection of endoscopic images and videos | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- neoplasia detection rate
- timeFrame
- during the procedure, up to 24 weeks, at 1 year, through study completion
- description
- neoplasia detection rate of the AI algorithms in different locations of the GI tract.
Secondary outcomes (2)
- measure
- Accuracy of AI diagnosis
- timeFrame
- during the procedure, up to 24 weeks, at 1 year, through study completion
- description
- Accuracy of real time optical diagnosis (characterization) of GI neoplasia by the AI algorithm.
- measure
- Endoscopist neoplasia detection rate
- timeFrame
- during the procedure, up to 24 weeks, at 1 year, through study completion
- description
- Detection rate of endoscopists at various levels of experience
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: -The participant must meet ALL of the following criteria to be considered eligible for the study: * Male or Female, aged 18 years or above. * Requiring gastroscopy and/or colonoscopy to investigate gastrointestinal symptoms, or as part of screening or ongoing surveillance of GI neoplasia. * Participant is willing and able to give informed consent for participation in the study. Exclusion Criteria The participant may not enter the study if ANY of the following apply: * Patients with endoscopically active severe oesophagitis * Poor bowel preparation
References
Publications (0)
Data not yet available
No reference posted for this study.